CoChat

In Vitro Effects of Cyclosporine A and Tacrolimus on Regulatory T-Cell Proliferation and Function

Miroux, Céline, Morales, Olivier, Ghazal, Khaldoun, Othman, Samia Ben, de Launoit, Yvan, Pancré, Véronique, Conti, Filomena, Delhem, Nadira · 2012 · Transplantation

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Liver transplantation is the treatment of end-stage liver diseases, including hepatitis C. Immunosuppression prevents graft rejection but seems to accelerate the recurrence of hepatitis C. Regulatory T cells (Tregs) may be beneficial in tolerance but deleterious in recurrent hepatitis C. We evaluated the effects of cyclosporine or tacrolimus, the principal immunosuppressive drugs, on Treg proliferation and function. METHODS: Human Tregs were isolated from healthy donors and cultured with cyclosporine, tacrolimus, or NIM811, a cyclosporine analog devoid of calcineurin-inhibiting activity. Treg proliferation and suppressive activity were assessed. The phenotype, cytokine production, and phosphorylation profile of nuclear factor of activated T cell of Tregs were also analyzed. RESULTS: Cyclosporine and tacrolimus both decreased Treg proliferation, but only low doses of cyclosporine reduced Treg activity, by inducing the production of interleukin 2 proinflammatory cytokines in these cells. Moreover, NIM811 also inhibited Treg activity. The phosphorylation of nuclear factor of activated T cell in Tregs was not altered by cyclosporine, suggesting that the effects of this drug are independent of the calcineurin pathway. CONCLUSION: In summary, low doses of cyclosporine inhibit Treg activity, a finding that might explain the beneficial effect of this drug on hepatitis C recurrence. In contrast, by maintaining Treg activity, tacrolimus could be more helpful than cyclosporine in controlling rejection.

Overview

Integrity signals

Registry

Crossref · 10.1097/tp.0b013e3182590d8f

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. OGrady, 2007, Prognostication in acute liver failure: a tool or an anchor Liver T, ranspl, 6, 786
  2. Berenguer, 2002, Outcome of posttransplantation hepatitis C virus diseaseis it the host, the virus, or how we modify the host andor the virus Liver T, ranspl, 10, 889

Cited by

See all 117

Metadata

Authors
Miroux, C., Morales, O., Ghazal, K., Othman, S. B., de Launoit, Y., Pancré, V., Conti, F., & Delhem, N.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Inserm (FR)
Venue
Transplantation
Published
2012-07-27
Volume
94
Issue
2
Pages
123-131
ISSN
0041-1337 (ISSN-L)
OpenAlex
W1995250629
Cited by
117
References
46
Citations by year
2026: 7 · 2025: 10 · 2024: 9 · 2023: 7 · 2022: 7 · 2021: 13 · 2020: 9 · 2019: 6 · 2018: 11 · 2017: 3 · 2016: 5 · 2015: 10 · 2014: 14 · 2013: 4 · 2012: 2
FWCI
4.18
Type
journal article
Language
en
Open access
closed
Locations
  • Transplantation (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords
cyclosporine, tacrolimus, regulatory T cells, Treg proliferation, immunosuppression, liver transplantation, recurrent hepatitis C, calcineurin inhibitors, NIM811, interleukin-2, graft rejection, Treg suppressive function
MeSH terms
Cells, Cultured, Humans, Immunosuppressive Agents, Lymphocyte Activation, Phosphorylation, Liver Transplantation, Immunophenotyping, Cytokines, Tacrolimus, Cyclosporine, T-Lymphocytes, Regulatory, NFATC Transcription Factors, Calcineurin Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.